Reddrop DX
Designer and manufacturer of a next-generation capillary blood collection system for remote diagnostics, telehealth, and high-throughput laboratories. Offers a single-use, one-click capillary blood collection device paired with automation-ready tubes, claims up to 1 mL capillary blood collection, FDA 510(k) clearance for the device class, and patents covering the technology. Targets integration with digital health platforms and scale manufacturing.
Industries
Nr. of Employees
small (1-50)
Patents
Products
RedDrop One - Demo Unit
Patented, single-use capillary blood collection device with integrated sharps injury prevention and one-finger activation; provided as a demonstration unit not for diagnostic use.
RedDrop One - Demo Unit
Patented, single-use capillary blood collection device with integrated sharps injury prevention and one-finger activation; provided as a demonstration unit not for diagnostic use.
Services
Provision of demonstration units and sample kits for evaluation; consultation for workflow integration and purchasing; configuration for custom branded kits.
Provision of demonstration units and sample kits for evaluation; consultation for workflow integration and purchasing; configuration for custom branded kits.
Expertise Areas
- Capillary blood collection
- Remote sample collection for telehealth and decentralized clinical trials
- Automation-compatible sample workflows (direct-to-tube)
- Device design and human factors for self-collection
Key Technologies
- Capillary blood collection
- Single-use lancet with sharps injury prevention
- Direct-to-tube collection
- Automation-compatible 1 mL collection tubes
News & Updates
Discussion of operational and financial impacts of failed remote blood collections and how a higher-yield, more consistent capillary collection system can reduce redraws and costs.
Overview of claims around higher sample volumes, automation compatibility, manufacturing scale, and partner support for remote diagnostics workflows.
Explains importance of sample volume for multi-analyte testing and claims capability to provide up to 1 mL of capillary blood compared to lower-volume alternatives.
Summary of an independent LabCorp poster comparing device volume, flow rate, pain, hemolysis, and concordance with venous samples; reports favorable volume and acceptable hemolysis indices.
Stated FDA 510(k) clearance for the single-use blood lancet device (510(k) No. K234081).
Reference to a LabCorp device comparison poster reporting strong sample volume, acceptable hemolysis, low pain scores, and concordance with venous samples.
Discussion of operational and financial impacts of failed remote blood collections and how a higher-yield, more consistent capillary collection system can reduce redraws and costs.
Overview of claims around higher sample volumes, automation compatibility, manufacturing scale, and partner support for remote diagnostics workflows.
Explains importance of sample volume for multi-analyte testing and claims capability to provide up to 1 mL of capillary blood compared to lower-volume alternatives.
Summary of an independent LabCorp poster comparing device volume, flow rate, pain, hemolysis, and concordance with venous samples; reports favorable volume and acceptable hemolysis indices.
Stated FDA 510(k) clearance for the single-use blood lancet device (510(k) No. K234081).
Reference to a LabCorp device comparison poster reporting strong sample volume, acceptable hemolysis, low pain scores, and concordance with venous samples.